Deliver Your News to the World

Cryobanks International Gets Price Target of $6.25


(CybeRelease, April 6, 2006) - Lake Harmony, PA - Cryobanks International (OTC BB: BTEM) received a price target of $6.25 and recently entered into its thirteenth year of business. “In our first twelve years, we have seen the industry grow from a vision into a reality. As we look forward, we hope industry growth continues and that cord blood donations become a routine part of delivery,” says Dwight Brunoehler, President & CEO of Cryobanks International.

Cryobanks International is a pioneer in collection, isolation and storage technologies for cord blood stem cells. The company was the first and remains the only company in the country to accept cord blood donations from anywhere in the continental United States, year round.

For in-depth analyst coverage, go to

To read the complete release, go to

CybeRelease Gainers are NIC Inc. (Nasdaq: EGOV), Silicon Motion Technology Corporation (Nasdaq: SIMO), Pacific Ethanol, Inc. (Nasdaq: PEIX), Centillium Communications, Inc. (Nasdaq: CTLM), Career Education Corporation (Nasdaq: CECO), Pathmark Stores, Inc. (Nasdaq: PTMK), Datalink Corporation (Nasdaq: DTLK) and Century Aluminum Company (Nasdaq: CENX).

CybeRelease Decliners are Imperial Sugar Company (Nasdaq: IPSU), Astea International, Inc. (Nasdaq: ATEA), Standard Management Corporation (Nasdaq: SMAN), QSound Labs, Inc. (Nasdaq: QSND), Lipid Sciences Incorporated (Nasdaq: LIPD), Citizens Financial Corporation (Nasdaq: CNFL), LaserCard Corporation (Nasdaq: LCRD) and MISONIX, Inc. (Nasdaq: MSON).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $695.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.